Sky Medical Technology
Sky Medical develops bioelectronic devices to treat a wide range of acute and chronic circulatory conditions.
Sky Medical develops bioelectronic devices to treat a wide range of acute and chronic circulatory conditions.
Sky Medical Technology is a UK-based biotechnology company that specializes in developing bioelectronic devices integrated with OnPulse neuromodulation technology. The devices are designed to prevent and treat a wide range of acute and chronic circulatory conditions, such as venous thromboembolism (VTE), edema reduction after surgery, and the healing of venous and arterial leg ulcers and chronic wounds.
Founded in 2006, the company has achieved significant milestones in the medical industry. Following extensive clinical research, OnPulse is now implemented in hospitals and community care centers, accelerating patient recovery post-surgery and healing chronic venous and diabetic ulcers. Moreover, the technology is favored by elite sports teams, including the US Olympic Hockey team, NFL, MLS, MLB, NBA, and NHL clubs, as well as renowned football teams like AC Milan, Chelsea, and West Ham.
Previously, Sky Medical secured a $16.00MSecondary Market investment from Trudell Medical on 01 October 2017. Through neuromodulation of the peroneal nerve, the company aims to enhance patients' quality of life by naturally improving bodily functions, making it a promising venture in the biotechnology and healthcare industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Secondary Market | $16.00M | 1 | Trudell Medical | 01 Oct 2017 |
| Series B | $13.50M | 5 |
|
01 Sep 2017 |
| Grant | $1.40M | 2 |
|
18 Jun 2015 |
| Series A | $15.00M | 4 |
|
01 Feb 2015 |
| Venture Round | $13.00M | 4 |
|
01 Feb 2014 |
No recent news or press coverage available for Sky Medical Technology.
We care about your data, and we'd love to use cookies make your experience better.
